We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

10 hedge funds and large institutions have $1.08M invested in ENDRA Life Sciences in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1.02M → $1.08M (+$69K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

23% less funds holding

Funds holding: 13 → 10 (-3)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$20.7K
2
Morgan Stanley
Morgan Stanley
New York
+$10.3K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$82.6K
2
VF
Virtu Financial
New York
-$65K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$51.6K
4
TSS
Two Sigma Securities
New York
-$18K
5
UBS Group
UBS Group
Switzerland
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$305K -$51.6K -5 -15%
Morgan Stanley
2
Morgan Stanley
New York
$265K +$10.3K +1 +4%
NA
3
NewEdge Advisors
Louisiana
$201K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$105K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$86K -$82.6K -8 -50%
State Street
6
State Street
Massachusetts
$32K – – –
Osaic Holdings
7
Osaic Holdings
Arizona
$28K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$23K +$20.7K +2 New
Northern Trust
9
Northern Trust
Illinois
$19K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$8K – – –
IC
11
IEQ Capital
California
$5K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$5K – – –
BlackRock
13
BlackRock
New York
$1K – – –
National Bank of Canada
14
National Bank of Canada
Quebec, Canada
$1K – – –
WAM
15
Worth Asset Management
Texas
$1K – – –
VF
16
Virtu Financial
New York
– -$65K -8 Closed
TSS
17
Two Sigma Securities
New York
– -$18K -2 Closed
Citigroup
18
Citigroup
New York
– -$7K -1 Closed
UBS Group
19
UBS Group
Switzerland
– -$9K -1 Closed
Skandinaviska Enskilda Banken (SEB)
20
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$1K – –

NDRA Hedge Fund Activity: Q3 2022 in Review

10 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2022, worth a combined $1.08M — up 6.8% from $1.02M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NDRA and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $20.7K. The largest seller was Renaissance Technologies, cutting an estimated $82.6K.

  • 10 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2022, down from 13 in Q2 2022.
  • Funds reported $1.08M of ENDRA Life Sciences stock for Q3 2022, up 6.8% quarter-over-quarter.
  • 1 fund opened new ENDRA Life Sciences positions in Q3 2022 and 4 closed out, a net change of -3 holders.
  • The largest ENDRA Life Sciences buyer in Q3 2022 was Citadel Advisors, an estimated $20.7K added.
  • The largest ENDRA Life Sciences seller in Q3 2022 was Renaissance Technologies, an estimated $82.6K sold.

Based on aggregated 13F filings for Q3 2022.